Medicine and Dentistry
Osteolysis
100%
Abaloparatide
88%
Bone Strength
86%
Bone Mass
85%
Osteopenia
68%
Hypoxia
68%
Parathyroid Hormone
64%
Botulinum Toxin A
57%
Bone Density
48%
Teriparatide
44%
Hindlimb
42%
Botulinum Toxin
37%
Bone Histomorphometry
28%
Cancellous Bone
28%
Bone Defect
24%
Sarcopenia
24%
Glucocorticoid
22%
Systematic Review
22%
Receptor
22%
Activin
22%
Intermittent Hypoxia
22%
Dabigatran Etexilate
22%
Zoledronic Acid
22%
Sclerostin
22%
Growth Hormone
22%
Acetazolamide
22%
Secukinumab
22%
Climatotherapy
22%
Psoriasis
22%
Disease
22%
Cortical Bone
18%
Diaphysis
16%
Metaphysis
16%
Epiphysis
14%
Altitude Disease
13%
Monotherapy
13%
Deterioration
11%
Femoral Neck
11%
High-Altitude Pulmonary Edema
10%
High-Altitude Cerebral Edema
10%
Trabecula
10%
Osteoporosis
9%
X-Ray Microtomography
9%
Ossification
9%
Nevus
8%
Human Study
8%
Fracture
7%
Paralysis
7%
Neck
7%
Signal Transduction
7%
Biochemistry, Genetics and Molecular Biology
Osteolysis
87%
Botulinum Toxin
86%
Animal Model
69%
Mouse
67%
Parathyroid Hormone
66%
Bone Strength
64%
Bone Mass
44%
Bone Density
41%
Sclerostin
22%
Glucocorticoid
22%
Growth Hormone
22%
Bovine Somatotropin
22%
Monospecific Antibody
22%
NMRI Mouse
22%
Mole (Insectivora)
19%
Medline
15%
Embase
15%
Wistar Rat
10%
Signal Transduction
7%
Data Extraction
5%
Experimental Animal
5%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse
71%
Abaloparatide
66%
Botulinum Toxin
37%
Preclinical Study
24%
Disease
24%
Parathyroid hormone[1-34]
24%
Clinical Study
24%
Glucocorticoid
24%
Bone Defect
24%
Osteopenia
24%
Transgenic Animal
22%
Zoledronic Acid
22%
Hypoxia
22%
Swiss Webster Mouse
22%
Acetazolamide
22%
Dabigatran Etexilate
22%
Neurologic Disease
22%
Observational Study
22%
Amyotrophic Lateral Sclerosis
22%
Cerebral Palsy
22%
Sclerostin
22%
Parathyroid Hormone
20%
Altitude Disease
11%
Mole (Insectivora)
8%
Placebo
8%
Monotherapy
7%
Fracture
7%
Hormone Inhibitor
7%
Prednisolone
6%
Experimental Animal
5%
